Visus’ BRIMOCHOL PF meets primary endpoints in phase 3 trial in presbyopia
The late-stage trial compared the investigational ophthalmic solution against carbachol monotherapy topical ophthalmic solution as well as brimonidine…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 May 23
The late-stage trial compared the investigational ophthalmic solution against carbachol monotherapy topical ophthalmic solution as well as brimonidine…
05 May 23
Due to the high prevalence of diabetes, much of the academic literature on wound care is centred around…
04 May 23
In the late-stage trial, the investigational amyloid plaque targeting therapy significantly decelerated cognitive and functional decline in patients…
04 May 23
Diabetic foot ulcers have the potential to carry a huge cost, both to patients – who can end…
03 May 23
Accurate diagnosis of gastroenteritis is paramount, given that it is highly infectious and poses health risks to the…
02 May 23
Although microbiology laboratories have witnessed a surge in molecular biology techniques over the last few years, bacterial culturing…
01 May 23
Sepsis is a leading cause of death in hospitals, and yet, there’s very little in the way of…
28 Apr 23
SURMOUNT-2 evaluated the efficacy and safety of tirzepatide for chronic weight management in 938 adults with obesity or…
28 Apr 23
In order to assist the World Health Organisation’s ‘End TB Strategy’ with the goal of reducing the global…
27 Apr 23
Dedicaid has built an AI-based clinical decision support software (CDSS) platform that produces indication-specific CDSS applications from available…